دورية أكاديمية

GSK-3 inhibitor elraglusib (9-ING-41) to enhance tumor-infiltrating immune cell activation in tumor biopsies and synergize with anti-PD-L1 in a murine model of colorectal cancer.

التفاصيل البيبلوغرافية
العنوان: GSK-3 inhibitor elraglusib (9-ING-41) to enhance tumor-infiltrating immune cell activation in tumor biopsies and synergize with anti-PD-L1 in a murine model of colorectal cancer.
المؤلفون: El-Deiry, Wafik S., Huntington, Kelsey, Louie, Anna, Srinivasan, Praveen, Schorl, Cristoph, Lu, Shaolei, Silverberg, David, Newhouse, Daniel, Wu, Zhijin, Zhou, Lanlan, Ryspayeva, Dinara, Borden, Brittany, Giles, Francis J., Dooner, Mark, Carneiro, Benedito A.
المصدر: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe15138-e15138, 1p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0732183X
DOI:10.1200/JCO.2023.41.16_suppl.e15138